Protein polymer-based nanoparticles: fabrication and medical applications

K DeFrates, T Markiewicz, P Gallo, A Rack… - International journal of …, 2018 - mdpi.com
Nanoparticles are particles that range in size from about 1–1000 nanometers in diameter,
about one thousand times smaller than the average cell in a human body. Their small size …

Recent advances in gelatin-based therapeutics

MC Echave, R Hernáez-Moya, L Iturriaga… - Expert opinion on …, 2019 - Taylor & Francis
Introduction: Biomaterials have provided a wide range of exciting opportunities in tissue
engineering and regenerative medicine. Gelatin, a collagen-derived natural biopolymer, has …

Modified gelatin nanoparticles for gene delivery

O Madkhali, G Mekhail, SD Wettig - International Journal of Pharmaceutics, 2019 - Elsevier
Gelatin nanoparticles (GNPs) are one of the most extensively used natural polymers for
gene therapy. With advantages of being biodegradable, biocompatible, low cost and easily …

[HTML][HTML] Current applications and prospects of nanoparticles for antifungal drug delivery

S Nami, A Aghebati-Maleki, L Aghebati-Maleki - EXCLI journal, 2021 - ncbi.nlm.nih.gov
Currently, the significance of fungi as human pathogens is not medically concealed in the
world. Consequently, suitable recognition and treatment of such infections are of great …

Antiviral therapies: advances and perspectives

BC Gonçalves, MG Lopes Barbosa… - Fundamental & …, 2021 - Wiley Online Library
Viral infections cause high morbidity and mortality, threaten public health, and impose a
socioeconomic burden. We have seen the recent emergence of SARS‐CoV‐2 (Severe …

Drug delivery of gelatin nanoparticles as a biodegradable polymer for the treatment of infectious diseases: perspectives and challenges

OA Madkhali - Polymers, 2023 - mdpi.com
In recent years, there has been a growing interest in the use of gelatin nanoparticles (GNPs)
for the treatment of infectious diseases. The inherent properties of these nanoparticles make …

Unintended effects of drug carriers: Big issues of small particles

H Parhiz, M Khoshnejad, JW Myerson, E Hood… - Advanced drug delivery …, 2018 - Elsevier
Humoral and cellular host defense mechanisms including diverse phagocytes, leukocytes,
and immune cells have evolved over millions of years to protect the body from microbes and …

Nanomedicine as a future therapeutic approach for Hepatitis C virus

NH Abd Ellah, HM Tawfeek, J John, HF Hetta - Nanomedicine, 2019 - Taylor & Francis
Hepatitis C virus (HCV) is not easily cleared from the human body and in most cases turned
into chronic infection. This chronicity is a major cause of liver damage, cirrhosis and …

A review on the nanotechnology-based approaches for managing sexually transmitted infections

A Zeb, N Khan, FA Shah, A Ullah, HI Choi… - Journal of …, 2024 - Springer
Abstract Background Sexually transmitted infections (STIs) are a major public health
concern, accounting for millions of new infections each year and a high mortality rate. Acute …

Natural biopolymeric nanoformulations for brain drug delivery

J Jampílek, K Král'ová - Nanocarriers for Brain Targeting, 2019 - taylorfrancis.com
The blood-brain barrier (BBB) prevents the passage of many drugs that target the central
nervous system (CNS). The BBB represents a structure with a complex cellular organization …